6-K ·Filed Jun 25, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No trading catalyst from this filing. Monitor upcoming clinical pipeline updates (e.g., data readouts for CAR T programs) or financing events for material price movement.
Final — all horizons settled through T+60d ⚠ clustered
CLLS ▼ -46.64% at T+60d
NEUTRAL call -46.64% · α vs SPY -52.75% · entry $2.83 → $1.51
T+1d
+3.89%
call +3.89% · α +2.24%
$2.94
settled 4mo ago
T+5d
+16.61%
call +16.61% · α +14.44%
$3.30
settled 4mo ago
T+20d
-2.12%
call -2.12% · α -3.38%
$2.77
settled 3mo ago
T+60d
-46.64%
call -46.64% · α -52.75%
$1.51
settled 5w ago
Price Chart
Loading chart...
Executive Summary
Cellectis reported results from its June 25, 2026 shareholders meeting, where 29 of 30 resolutions were adopted and only resolution 30 was rejected, following board recommendations. This is a routine governance update with no material financial or strategic impact.
Key Facts
- Shareholders meeting held June 25, 2026 with approximately 55.84% of voting rights exercised
- Resolutions 1 through 29 were adopted; resolution 30 was rejected in line with board recommendations
- No material financial, operational, or strategic disclosures beyond voting outcomes
Financial Impact
None — no financial figures disclosed
Risk Factors
- Routine governance filing with no stock-moving content expected
- No disclosure of pipeline, financial, or strategic catalysts
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004304 |
| Exhibit: exh_991.htm | 0001171843-26-004304 |
| Document: 0001171843-26-004304-index-headers.html | 0001171843-26-004304 |
| Document: 0001171843-26-004304-index.html | 0001171843-26-004304 |
| Document: 0001171843-26-004304.txt | 0001171843-26-004304 |
14 reports for CLLS
40% Hit rate @ T+60 Went positive at some point 4 of 6 best @ T+20▲ +35.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 6w ago | 6-K | $1.83 | awaiting T+60 | — | $1.02 (+44.26%) |
Sep 11, 2026 6w ago | Press Release | $1.83 | awaiting T+60 | — | $1.02 (−44.26%) |
Aug 6, 2026 11w ago | Press Release | $2.84 | awaiting T+60 | — | $1.02 (−64.02%) |
Jun 29, 2026 17w ago | Court Ruling | $3.00 $1.43 | ▼ −52.33% | ▼ −55.32% | $1.02 (−66.00%) |
Jun 25, 2026 17w ago | 6-K | $2.83 $1.51 | ▼ −46.64% | ▼ −52.75% | $1.02 (−63.96%) |
Jun 25, 2026 17w ago | 6-K | $2.83 $1.51 | ▼ −46.64% | ▼ −52.75% | $1.02 (−63.96%) |
Jun 11, 2026 19w ago | Press Release | $3.09 $3.24 | ▲ +4.85% | ▲ +0.46% | $1.02 (−66.99%) |
Jun 9, 2026 19w ago | 6-K | $3.18 $3.32 | ▲ +4.40% | ▼ −2.18% | $1.02 (−67.92%) |
May 12, 2026 24w ago | 6-K | $3.96 $2.69 | ▼ −32.07% | ▼ −36.45% | $1.02 (−74.24%) |
May 4, 2026 25w ago | 6-K | $3.76 $2.85 | ▼ −24.20% | ▼ −26.94% | $1.02 (−72.87%) |
Showing 10 of 14
US Market Status
Market Open — Closes in 1h 57m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers